Meeting
2012 ASCO Annual Meeting
Hypoxia-inducible factor (HIF) 1α and 2α as predictive markers of outcome to VEGFR tyrosine kinase inhibitors (TKI) in renal cell carcinoma (RCC).
Authors
M.I. Saez
Hospital Universitario Virgen de la Victoria, Malaga, Spain
M.I. Saez , Jose Manuel Trigo Perez , L.G. Perez-Rivas , L. Perez-Villa , R. Villatoro , A. Montesa , J.I. Cid , M. Leon , V. de Luque , C. Fernandez , C. Quero , B. Pajares , E. Alba
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer
Track
Genitourinary Cancer
Sub Track
Kidney Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 4630)
DOI
10.1200/jco.2012.30.15_suppl.4630
Abstract #
4630
Poster Bd #
8E
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Glutamine metabolism and VEGF analysis to elucidate and overcome the mechanism of tyrosine kinase inhibitor resistance in renal cell carcinoma.
First Author: Kento Morozumi
Poster
2021 Genitourinary Cancers Symposium
A dual drug therapy for sunitinib resistant RCC: An in vitro analysis.
First Author: Jacob W. Greenberg
Poster
2018 ASCO Annual Meeting
A meta-analysis of randomized controlled trials for efficacy and safety of vascular endothelial growth factor tyrosine kinase inhibitors (VEGF-TKIs) adjuvant therapy in high-risk renal cell cancer (RCC).
First Author: Irbaz Bin Riaz
Poster
2018 Genitourinary Cancers Symposium
Clinical validation of single nucleotide polymorphisms (SNPs) as predictive biomarkers in localized and metastatic renal cell cancer (RCC).
First Author: Carmen Garrigos